1 min to read S-1 Filing Posted on February 1, 2023 S-1 – Inhibikase Therapeutics, Inc. (0001750149) (Filer) Filed: 2023-02-02 AccNo: 0001193125-23-021876 Size: 25 MB Source: S-1 – Inhibikase Therapeutics, Inc. (0001750149) (Filer) share tweet share SPAC Promoters Lost $1B+ in 2022, and There’s More Pain to Come – 24/7 Wall St.By the Numbers: Four Practices Big Law Firms Need to Power 2023 – Bloomberg LawSPACs: Are You Really Ready To Commit?Why Buy a SPAC Before It Identifies a Target? Tags: S-1 Filing